Open-Label, Randomized, Split-Face Study to Evaluate the Efficacy, Safety and Subject Satisfaction of Pain Management During and After Restylane Dermal Filler Injections for the Correction of Nasolabial Folds

Trial Profile

Open-Label, Randomized, Split-Face Study to Evaluate the Efficacy, Safety and Subject Satisfaction of Pain Management During and After Restylane Dermal Filler Injections for the Correction of Nasolabial Folds

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 25 Mar 2014

At a glance

  • Drugs Benzocaine; Lidocaine/tetracaine
  • Indications Injection site pain
  • Focus Therapeutic Use
  • Sponsors Galderma
  • Most Recent Events

    • 03 Feb 2010 Patient numbers amended from 57 to 51 as reported by ClinicalTrials.gov.
    • 30 Sep 2008 Planned end date changed from 1 Oct 2008 to 1 Sep 2008 as reported by ClinicalTrials.gov.
    • 30 Sep 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top